SIRT6 increased the levels of Ca2+-mobilizing second messengers and enhanced the expression of proinflammatory cytokines in pancreatic cancer, linking SIRT6 with a cancer cell proinflammatory phenotype and migratory propensity (91). Here, SIRT6 is linked to familial pancreatic carcinoma.